Hinova Pharmaceuticals Inc. is a biopharmaceutical company based in ChengDu, China, focused on the research, development, and commercialization of innovative therapies. The organization specializes in addressing unmet medical needs through advanced drug discovery and development processes. Hinova's primary research domains include oncology and autoimmune diseases, leveraging cutting-edge technology to create effective treatment solutions. The company is committed to enhancing patient outcomes and contributing to the global healthcare landscape.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

12 Patents

#16 in ChengDu

#2,353 in China

#48,129 in the World

ChengDu, China

Hinova Pharmaceuticals Inc.

Forward Citations = 3

26 inventors:

Yuanwei Chen (12 out of 12 patents)

Xinghai Li (10 out of 10 patents)

Wu Du (7 out of 7 patents)

4. Kun Wen (5 out of 5 patents)

5. Shaohua Zhang (4 out of 17 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Hinova Pharmaceuticals Inc.. Retrieved from https://idiyas.com/company/hinova-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

11 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]